The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real‐World Implementation. Issue 2 (11th March 2013)

• Record Type: Journal Article
• Authors: Shuldiner, A R; Relling, M V; Peterson, J F; Hicks, K; Freimuth, R R; Sadee, W; Pereira, N L; Roden, D M; Johnson, J A; Klein, T E; Pharmacogenomics Research Network Translational Pharmacogenetics Program Group
• Is Part Of: Clinical pharmacology & therapeutics. Volume 94:Issue 2(2013)
• Page Start: 207
• Page End: 210
• Publication Date: 2013-03-11
• Subjects: Pharmacology -- Periodicals; Therapeutics -- Periodicals; 615.5
• DOI: 10.1038/clpt.2013.59
• Languages: English
• ISSNs: 0009-9236

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The pace of discovery of potentially actionable pharmacogenetic variants has increased dramatically in recent years. However, the implementation of this new knowledge for individualized patient care has been slow. The Pharmacogenomics Research Network (PGRN) Translational Pharmacogenetics Program seeks to identify barriers and develop real‐world solutions to implementation of evidence‐based pharmacogenetic tests in diverse health‐care settings. Dissemination of the resulting toolbox of "implementation best practices" will prove useful to a broad audience.</p> <p> <italic>Clinical Pharmacology &amp; Therapeutics</italic> (2013); <bold>94</bold> 2, 207–210. doi:<ext-link ext-link-type="doi" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">10.1038/clpt.2013.59</ext-link></p> </abstract>